Bigham

Pathfinder Bancorp, Inc. Announces the Retirement of Chief Financial Officer and Names Successor

Retrieved on: 
Wednesday, May 8, 2024
Berkshire Bank, CFO, St. Bonaventure University, Small business, Pathfinder, Canisius College, Treasury, Accounting, State university system, State, Business administration, Knowledge, Finance Division, CPA, Senior, Bank, Bigham, Financial services, Judgement, Marketing, MBA, Five Star Bank, First Niagara Bank, M&T Bank, Financial plan, First, Certified Public Accountant, Growth, Management

Justin K. Bigham, CPA, 50, has been named to succeed Rusnak as Senior Vice President, Chief Financial Officer.

Key Points: 
  • Justin K. Bigham, CPA, 50, has been named to succeed Rusnak as Senior Vice President, Chief Financial Officer.
  • James A. Dowd, President and Chief Executive Officer, said, "Walter has been a great asset to Pathfinder Bank.
  • Bigham comes to Pathfinder Bank with more than 25 years’ experience and an impressive background in Financial Services.
  • Bigham has served in several key roles at various large public companies including his most recent position as Executive Vice President and Chief Community Banking Officer at Five Star Bank, after serving previously as their Chief Financial Officer.

Dycom Announces Acquisition of Bigham Cable Construction, Inc.

Retrieved on: 
Wednesday, August 23, 2023
DY, Bigham, PALM, Acquisition, BEACH, Southeastern United States, NYSE, Telecommunications, Retail, Internet service provider

PALM BEACH GARDENS, Fla., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Dycom Industries, Inc. (NYSE: DY) today announced that it has acquired Bigham Cable Construction, Inc. Bigham provides telecommunications construction services in the southeastern United States and generated approximately $140 million of revenue over the last twelve months.

Key Points: 
  • PALM BEACH GARDENS, Fla., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Dycom Industries, Inc. (NYSE: DY) today announced that it has acquired Bigham Cable Construction, Inc. Bigham provides telecommunications construction services in the southeastern United States and generated approximately $140 million of revenue over the last twelve months.
  • The acquisition strengthens Dycom’s customer base and geographic scope and expands its ability to further address growth opportunities in rural broadband deployments.

Carbone Fine Food Appoints Terry Bigham As Chief Sales Officer

Retrieved on: 
Tuesday, June 13, 2023
Head, CPG, Garlic, Sale, McCormick, Acquisition, Growth, Tate, Sales, Bigham

NEW YORK, June 13, 2023 /PRNewswire/ -- Today, Carbone Fine Food, announces the appointment of experienced sales executive Terry Bigham as the brand's Chief Sales Officer. With over twenty-five years of experience, Bigham brings an exceptional track record in driving sales growth and fostering strong customer relationships to the Carbone Fine Food team.

Key Points: 
  • NEW YORK, June 13, 2023 /PRNewswire/ -- Today, Carbone Fine Food, announces the appointment of experienced sales executive Terry Bigham as the brand's Chief Sales Officer.
  • With over twenty-five years of experience, Bigham brings an exceptional track record in driving sales growth and fostering strong customer relationships to the Carbone Fine Food team.
  • In his new role as Chief Sales Officer, Bigham will spearhead strategic sales initiatives, expand market presence, and drive revenue growth for the Carbone Fine Food brand.
  • "We are delighted to welcome Terry Bigham to our team as the Chief Sales Officer," said Eric Skae, CEO of Carbone Fine Food.

Nutcracker Therapeutics Raises $167 Million in Series C Financing to Advance its mRNA Therapeutics and First-of-its-Kind Biochip-based Manufacturing Platform

Retrieved on: 
Monday, March 14, 2022
Software, Research, Pharmaceutical, Oncology, Technology, Genetics, Semiconductor, Science, Engineering, Nanotechnology, Biotechnology, Health, Manufacturing, Thakeham, RNA transfection, Partnership, Therapy, Cancer, Bigham, Leadership, Nutcracker, Patient, Technology, Gilead Sciences, COVID-19, CEO, RNA, Vaccine, Pharmaceutical industry

Nutcracker Therapeutics, Inc., a biotech company developing RNA therapeutics using its proprietary biochip-based manufacturing platform, today announced it has raised $167 million in Series C financing led by ARCH Venture Partners.

Key Points: 
  • Nutcracker Therapeutics, Inc., a biotech company developing RNA therapeutics using its proprietary biochip-based manufacturing platform, today announced it has raised $167 million in Series C financing led by ARCH Venture Partners.
  • Nutcracker Therapeutics RNA manufacturing platform is at the core of the companys therapeutic effort.
  • Nutcracker Therapeutics is well-positioned to develop RNA therapeutics in a scalable and efficient manner with its innovative platform.
  • Nutcracker Therapeutics is an RNA therapeutics company that has combined the power of advanced engineering with high-precision biosynthesis to deploy a complete RNA therapeutics platform.

The Bright Side of Gaming: Agility and Focus. Interview with American RallyCross Driver, Cabot "FollowTheHam" Bigham

Retrieved on: 
Friday, February 1, 2019
Bigham, Cabot

SAN FRANCISCO, Jan. 31, 2019 /PRNewswire-PRWeb/ -- There really is a bright side to gaming: agility and focus.

Key Points: 
  • SAN FRANCISCO, Jan. 31, 2019 /PRNewswire-PRWeb/ -- There really is a bright side to gaming: agility and focus.
  • Check out this new interview with American RallyCross Driver, Cabot "FollowTheHam" Bigham (Ep.105: http://bit.ly/2BU-EDS105 ).
  • In this episode of Evolving Digital Self, Dr. Heidi Forbes ste interviews her nephew, Cabot "Follow the Ham" Bigham, an American Rallycross Driver, on the focus, agility, speed, personal branding and wellbeing it takes to win.
  • Cabot Bigham is an American rallycross driver, born in 1996.